Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

No reported Financing Cash Flow figures are available to summarize.

Financing Cash Flow history

Currency unavailable · from the cash flow

No Financing Cash Flow data reported for this period type.

Financing Cash Flow vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Financing Cash Flow for ODTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ORKAOruka Therapeutics, Inc.LTM Sep 2026$830.71M USD+390.1%——
SYRESpyre Therapeutics, Inc.LTM Sep 2026$759.69M USD+242.5%+93.5%839.5%
ALMSAlumis Inc. Common StockLTM Jun 2026$360.93M USD+53.0%-72.7%4878.8%
IMUXImmunic, Inc.LTM Mar 2026$254.22M USD+330054.5%-11.9%—
ANABAnaptysBio, Inc.LTM Mar 2026$102.81M USD-191.7%—44.2%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$52.19M USD-29.8%—623.8%
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$41.61M USD+36.7%+6.7%14.8%
ODTXOdyssey Therapeutics, Inc.—— ———
AGMBAgomAb Therapeutics N.V. American Depositary Shares—— ———
Peer median (excluding ODTX) —+53.0%-2.6%623.8%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.